SuperworthTandem Diabetes Care market cap TNDM
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $1.2B
- Highest close in our data
- $9.6B
- Dec 2021
Tandem Diabetes Care is worth $1.2B at the close on Oct 23, 2026, at $17.43 a share.
That is up 20% over the last year and down 86% over five years.
Its highest close in our data was $9.6B in Dec 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.2B | $878.5M | $1.7B | −20% |
| 2025 | $1.5B | $731.1M | $2.4B | −37% |
| 2024 | $2.4B | $1.5B | $3.3B | +26% |
| 2023 | $1.9B | $931.2M | $3B | −33% |
| 2022 | $2.9B | $2.3B | $8.3B | −70% |
| 2021 | $9.6B | $4.9B | $9.6B | +61% |
| 2020 | $6B | $3B | $7.3B | +67% |
| 2019 | $3.6B | $2B | $4.2B | +66% |
| 2018 | $2.1B | $23.8M | $2.5B | +8863% |
| 2017 | $23.9M | $12.7M | $81.2M | −64% |
| 2016 | $65.9M | $55.2M | $337.8M | −81% |
| 2015 | $355.2M | $238M | $408.6M | +18% |
| 2014 | $301.5M | $263.4M | $418.5M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Tandem Diabetes Care's size, closest first, today.
| Company | Market cap |
|---|---|
| TNDMTandem Diabetes Care | $1.2B |
| BVSBioventus | $1.3B |
| CDRECadre | $1.3B |
| STAAStaar Surgical | $1.1B |
| IRMDIradimed | $1.1B |
| EYENational Vision | $1.5B |
| LMATLemaitre Vascular | $1.9B |
| INSPInspire Medical Systems | $2.1B |
| MOVMovado | $701.9M |
| UFPTUFP Technologies | $2.3B |
| MDXGMimedx | $569.9M |
| Peer median | $1.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Tandem Diabetes Care
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.